List of Tables
    Table 1. Gastroesophageal Reflux Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Gastroesophageal Reflux Drugs Market Trends
    Table 3. Gastroesophageal Reflux Drugs Market Drivers
    Table 4. Gastroesophageal Reflux Drugs Market Challenges
    Table 5. Gastroesophageal Reflux Drugs Market Restraints
    Table 6. Global Gastroesophageal Reflux Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Gastroesophageal Reflux Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Gastroesophageal Reflux Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Gastroesophageal Reflux Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Gastroesophageal Reflux Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Gastroesophageal Reflux Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Gastroesophageal Reflux Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Gastroesophageal Reflux Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Gastroesophageal Reflux Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Gastroesophageal Reflux Drugs Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Gastroesophageal Reflux Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Gastroesophageal Reflux Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Drugs as of 2021)
    Table 18. Top Players of Gastroesophageal Reflux Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Gastroesophageal Reflux Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Gastroesophageal Reflux Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Gastroesophageal Reflux Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Gastroesophageal Reflux Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Gastroesophageal Reflux Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Gastroesophageal Reflux Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Gastroesophageal Reflux Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Gastroesophageal Reflux Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Gastroesophageal Reflux Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Gastroesophageal Reflux Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Gastroesophageal Reflux Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Gastroesophageal Reflux Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Gastroesophageal Reflux Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Gastroesophageal Reflux Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Gastroesophageal Reflux Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Gastroesophageal Reflux Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Gastroesophageal Reflux Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Gastroesophageal Reflux Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Gastroesophageal Reflux Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Gastroesophageal Reflux Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Gastroesophageal Reflux Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Gastroesophageal Reflux Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Bayer Corporation Information
    Table 43. Bayer Description and Business Overview
    Table 44. Bayer Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Bayer Gastroesophageal Reflux Drugs Product
    Table 46. Bayer Recent Development
    Table 47. Cadila Pharmaceuticals Corporation Information
    Table 48. Cadila Pharmaceuticals Description and Business Overview
    Table 49. Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Cadila Pharmaceuticals Product
    Table 51. Cadila Pharmaceuticals Recent Development
    Table 52. AstraZeneca Corporation Information
    Table 53. AstraZeneca Description and Business Overview
    Table 54. AstraZeneca Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. AstraZeneca Product
    Table 56. AstraZeneca Recent Development
    Table 57. Jiangsu Aosaikang Corporation Information
    Table 58. Jiangsu Aosaikang Description and Business Overview
    Table 59. Jiangsu Aosaikang Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Jiangsu Aosaikang Product
    Table 61. Jiangsu Aosaikang Recent Development
    Table 62. Eisai Corporation Information
    Table 63. Eisai Description and Business Overview
    Table 64. Eisai Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Eisai Product
    Table 66. Eisai Recent Development
    Table 67. Pfizer Corporation Information
    Table 68. Pfizer Description and Business Overview
    Table 69. Pfizer Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Pfizer Product
    Table 71. Pfizer Recent Development
    Table 72. Altana Pharma Corporation Information
    Table 73. Altana Pharma Description and Business Overview
    Table 74. Altana Pharma Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Altana Pharma Product
    Table 76. Altana Pharma Recent Development
    Table 77. Takeda Corporation Information
    Table 78. Takeda Description and Business Overview
    Table 79. Takeda Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Takeda Product
    Table 81. Takeda Recent Development
    Table 82. NCPC Corporation Information
    Table 83. NCPC Description and Business Overview
    Table 84. NCPC Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. NCPC Product
    Table 86. NCPC Recent Development
    Table 87. Luoxin Corporation Information
    Table 88. Luoxin Description and Business Overview
    Table 89. Luoxin Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Luoxin Product
    Table 91. Luoxin Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Gastroesophageal Reflux Drugs Customers List
    Table 95. Gastroesophageal Reflux Drugs Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Gastroesophageal Reflux Drugs Product Picture
    Figure 2. Global Gastroesophageal Reflux Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Gastroesophageal Reflux Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Gastroesophageal Reflux Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Gastroesophageal Reflux Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Gastroesophageal Reflux Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Gastroesophageal Reflux Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Gastroesophageal Reflux Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Gastroesophageal Reflux Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Gastroesophageal Reflux Drugs Report Years Considered
    Figure 11. Product Picture of Esomeprazole
    Figure 12. Product Picture of Lansoprazole
    Figure 13. Product Picture of Omeprazole
    Figure 14. Product Picture of Rbeprazole
    Figure 15. Product Picture of Dexlansoprazole
    Figure 16. Product Picture of Others
    Figure 17. Global Gastroesophageal Reflux Drugs Market Share by Type in 2022 & 2028
    Figure 18. Global Gastroesophageal Reflux Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 19. Global Gastroesophageal Reflux Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 20. Global Gastroesophageal Reflux Drugs Sales by Type (2017-2028) & (K Units)
    Figure 21. Global Gastroesophageal Reflux Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 22. Global Gastroesophageal Reflux Drugs Price by Type (2017-2028) & (US$/Unit)
    Figure 23. United States Gastroesophageal Reflux Drugs Market Share by Type in 2022 & 2028
    Figure 24. United States Gastroesophageal Reflux Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 25. United States Gastroesophageal Reflux Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 26. United States Gastroesophageal Reflux Drugs Sales by Type (2017-2028) & (K Units)
    Figure 27. United States Gastroesophageal Reflux Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 28. United States Gastroesophageal Reflux Drugs Price by Type (2017-2028) & (US$/Unit)
    Figure 29. Product Picture of Hospitals
    Figure 30. Product Picture of Ambulatory surgical centers
    Figure 31. Product Picture of Specialty clinics
    Figure 32. Product Picture of Others
    Figure 33. Global Gastroesophageal Reflux Drugs Market Share by Application in 2022 & 2028
    Figure 34. Global Gastroesophageal Reflux Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. Global Gastroesophageal Reflux Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 36. Global Gastroesophageal Reflux Drugs Sales by Application (2017-2028) & (K Units)
    Figure 37. Global Gastroesophageal Reflux Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 38. Global Gastroesophageal Reflux Drugs Price by Application (2017-2028) & (US$/Unit)
    Figure 39. United States Gastroesophageal Reflux Drugs Market Share by Application in 2022 & 2028
    Figure 40. United States Gastroesophageal Reflux Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 41. United States Gastroesophageal Reflux Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 42. United States Gastroesophageal Reflux Drugs Sales by Application (2017-2028) & (K Units)
    Figure 43. United States Gastroesophageal Reflux Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 44. United States Gastroesophageal Reflux Drugs Price by Application (2017-2028) & (US$/Unit)
    Figure 45. North America Gastroesophageal Reflux Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. North America Gastroesophageal Reflux Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. U.S. Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Canada Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Europe Gastroesophageal Reflux Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 50. Europe Gastroesophageal Reflux Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 51. Germany Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. France Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.K. Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Italy Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Russia Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Asia-Pacific Gastroesophageal Reflux Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 57. Asia-Pacific Gastroesophageal Reflux Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 58. China Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Japan Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. South Korea Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. India Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Australia Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Taiwan Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Indonesia Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Thailand Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Malaysia Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Philippines Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Latin America Gastroesophageal Reflux Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Latin America Gastroesophageal Reflux Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Mexico Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Brazil Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Argentina Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Middle East & Africa Gastroesophageal Reflux Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 74. Middle East & Africa Gastroesophageal Reflux Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 75. Turkey Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Saudi Arabia Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. UAE Gastroesophageal Reflux Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. Gastroesophageal Reflux Drugs Value Chain
    Figure 79. Gastroesophageal Reflux Drugs Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed